시장보고서
상품코드
1441268

세계의 암 지지요법 약제 시장 규모, 점유율, 성장 분석, 유형별, 용도별, 산업별 시장 규모, 점유율, 성장 분석 - 산업 예측(2023-2030년)

Global Cancer Supportive Care Drugs Market Size, Share, Growth Analysis, By Type(ESA (Erythropoiesis-Stimulating Agents), G-CSFs (Granulocyte Colony-Stimulating Factors)), By Application(Breast Cancer, Lung Cancer) - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 암 지지요법 약제 시장 규모는 2022년 883억 달러로 평가되었습니다. 2023년 942억 2,000만 달러에서 2031년에는 1,582억 9,000만 달러에 달하고, 예측 기간(2024-2031년) 동안 6.70%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계 암 보조 치료제 시장은 암 치료의 부작용을 완화하고 암 환자의 전반적인 삶의 질을 개선하는 데 도움을 주고 있습니다. 화학요법, 방사선 치료, 표적 치료와 같은 치료법은 종종 부작용을 유발하는 경우가 많기 때문에 보조요법제는 증상 관리에 필수적입니다. 이 시장은 암 발병률 증가, 노인 인구 증가, 암 치료법의 발전 등의 요인으로 인해 크게 성장하고 있습니다. 지지요법은 구토제, 진통제, 조혈제 등 다양한 의약품을 포함하며, 치료의 부작용을 줄이기 위한 목적으로 사용됩니다. 지속적인 연구 개발 노력은 보다 정확하고 효과적인 지지요법을 개발하기 위해 집중되고 있습니다. 제약회사들은 암 치료와 지지요법을 통합한 종합적인 치료 옵션을 제공하기 위해 협력하고 있습니다. 암 치료법이 발전함에 따라 지지요법 약물에 대한 수요가 더욱 증가할 것으로 예상됩니다. 시장 성장의 주요 촉진요인으로는 환자 중심의 접근 방식과 치료 중 환자의 건강 유지의 중요성에 대한 인식이 높아지는 것을 들 수 있습니다. 치료와 관련된 부작용을 표적으로 삼고 환자의 편안함을 향상시키는 혁신적인 치료법의 개발은 세계 암 보조요법 시장의 미래를 형성하는 데 있어 매우 중요한 역할을 할 것으로 보입니다.

목차

주요 요약

  • 시장 개요
  • 번영과 쇠퇴

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 암 지지요법 약제 시장 : 유형별

  • 시장 개요
  • ESA (Erythropoiesis-Stimulating Agents)
  • G-CSFs (Granulocyte Colony-Stimulating Factors)
  • 항구토제
  • 비스포스포네이트
  • 오피오이드
  • NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
  • 기타

세계의 암 지지요법 약제 시장 : 용도별

  • 시장 개요
  • 유방암
  • 폐암
  • 결장직장암
  • 전립선암
  • 간암
  • 위암
  • 기타

세계의 암 지지요법 약제 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • Amgen Inc.(미국)
  • Johnson & Johnson(미국)
  • Roche Holding AG(스위스)
  • Amneal Pharmaceuticals LLC(미국)
  • Novartis AG(스위스)
  • Pfizer Inc.(미국)
  • Mylan N.V.(미국)
  • Bristol Myers Squibb(미국)
  • Merck & Co., Inc.(미국)
  • Ipsen Pharma(프랑스)
  • Eli Lilly and Company(미국)
  • Teva Pharmaceutical Industries Ltd.(이스라엘)
  • Helsinn Healthcare SA(스위스)
  • GlaxoSmithKline plc(영국)
  • F. Hoffmann-La Roche Ltd.(스위스)
  • Takeda Pharmaceutical Company Limited(일본)
  • Eisai Co., Ltd.(일본)
  • Astellas Pharma Inc.(일본)
  • Mundipharma International Limited(영국)
  • Sanofi(프랑스)
  • Bayer AG(독일)
  • AstraZeneca plc(영국)
  • Kyowa Kirin Co., Ltd.(일본)
  • Dr. Reddy's Laboratories Ltd.(인도)
  • Sun Pharmaceutical Industries Ltd.(인도)
LSH 24.04.11

Global Cancer Supportive Care Drugs Market size was valued at USD 88.3 billion in 2022 and is poised to grow from USD 94.22 billion in 2023 to USD 158.29 billion by 2031, growing at a CAGR of 6.70% during the forecast period (2024-2031).

The global market for cancer supportive care drugs is instrumental in alleviating the adverse effects of cancer treatments and improving the overall quality of life for cancer patients. Therapies like chemotherapy, radiation, and targeted treatments often bring about debilitating side effects, making supportive care drugs indispensable for symptom management. This market has experienced substantial expansion driven by factors such as rising cancer prevalence, a growing elderly population, and advancements in cancer therapies. Supportive care drugs encompass a diverse range of pharmaceuticals, including antiemetics, analgesics, hematopoietic agents, among others, aiming to mitigate treatment side effects. Continuous research and development efforts are focused on creating more precise and efficacious supportive care therapies. Pharmaceutical companies are collaborating to offer comprehensive treatment options integrating cancer therapies with supportive care drugs. Anticipated advancements in cancer treatment methods are expected to further drive the demand for supportive care drugs. Key drivers of the market's growth include a patient-centric approach and increased awareness of the importance of maintaining patient well-being during treatment. The ongoing development of innovative therapies targeting treatment-related side effects and enhancing patient comfort will play a pivotal role in shaping the future landscape of the global cancer supportive care drugs market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cancer Supportive Care Drugs Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Supportive Care Drugs Market Segmental Analysis

By Type, the market is segmented into ESA (Erythropoiesis-Stimulating Agents), G-CSFs (Granulocyte Colony-Stimulating Factors), Antiemetics, Bisphosphonates, Opioids, NSAIDs (Non-Steroidal Auto Inflammatory Drugs), Others. By Application, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Others. By distribution channel, the market is segmented into Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Cancer Supportive Care Drugs Market

The escalating worldwide incidence of cancer underscores the growing necessity for cancer supportive care medications. As more individuals undergo treatments such as chemotherapy, radiation therapy, and targeted therapies, the demand intensifies for managing the adverse effects associated with these interventions. Supportive care drugs play a crucial role in enhancing patients' quality of life by alleviating symptoms such as nausea, pain, anemia, and fatigue, thereby providing significant relief throughout their cancer treatment journey.

Restraints in the Global Cancer Supportive Care Drugs Market

The complex process of approving cancer supportive drugs stems from the necessity for rigorous clinical trials to ascertain their safety and efficacy. This intricate approval procedure, governed by regulatory barriers and stringent development and marketing guidelines, often leads to delays in introducing new medications to the market. Consequently, patients encounter challenges accessing innovative supportive care options, thereby limiting their treatment choices.

Market Trends of the Global Cancer Supportive Care Drugs Market

With the evolving landscape of cancer treatments tailored to individual patients, there's a growing recognition of the importance of personalized supportive care. This approach acknowledges the unique characteristics of each patient's cancer type, treatment regimen, and health status, leading to the development of specialized drugs to mitigate specific side effects and symptoms such as chemotherapy-induced nausea, vomiting, fatigue, and anemia. By enhancing the quality of life for patients and promoting treatment adherence, personalized supportive care not only addresses the challenges of cancer treatment but also enhances overall outcomes.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Cancer Supportive Care Drugs Market by Type

  • Market Overview
  • ESA (Erythropoiesis-Stimulating Agents)
  • G-CSFs (Granulocyte Colony-Stimulating Factors)
  • Antiemetics
  • Bisphosphonates
  • Opioids
  • NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
  • and Others

Global Cancer Supportive Care Drugs Market by Application

  • Market Overview
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Stomach Cancer
  • and Others

Global Cancer Supportive Care Drugs Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Amgen Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amneal Pharmaceuticals LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol Myers Squibb (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ipsen Pharma (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Helsinn Healthcare SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eisai Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Astellas Pharma Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mundipharma International Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kyowa Kirin Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Reddy's Laboratories Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제